Phoenix Holdings Ltd. Amicus Therapeutics, Inc. Transaction History

Phoenix Holdings Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$13.47 - $24.89 $3.82 Million - $7.05 Million	-283,406 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$12.89 - $15.89 $3.87 Million - $4.77 Million	-300,000 Reduced 51.42%	283,406 $3.77 Million
Q2 2020 Aug 10, 2020	SELL	$8.86 - $15.69 $5.49 Million - $9.73 Million	-620,000 Reduced 51.52%	583,406 $8.35 Million
Q1 2020 May 20, 2020	SELL	$6.63 - $11.16 $1.99 Million - $3.35 Million	-300,000 Reduced 19.95%	1,203,406 $10.9 Million
Q4 2019 Feb 18, 2020	BUY	$7.48 - $10.75 $2.49 Million - $3.57 Million	332,310 Added 28.38%	1,503,406 $14.5 Million

Q3 2019 Nov 18, 2019	BUY	$8.02 - $13.25 $9.39 Million - $15.5 Million	1,171,096 New	1,171,096 $8.96 Million

273

325M

841K

353K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.76B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.